Rb and Hippo tumor suppressor pathways in differentiation

Rb 和 Hippo 肿瘤抑制通路在分化中的作用

基本信息

  • 批准号:
    9355642
  • 负责人:
  • 金额:
    $ 33.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-15 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT In a multicellular organism, control of cell proliferation and differentiation is determined by the net output of multiple pathways. This is illustrated by cooperation between the well-known Rb tumor suppressor pathway and the emerging Hippo tumor suppressor pathway. However, these types of studies are intrinsically complex and therefore model organisms such as Drosophila are attractive alternatives to complement analogous studies in mammalian systems. This is due primarily to the relative simplicity yet high conservation of the Drosophila Rb and Hippo pathways. In the previous cycle of this grant, we explored the mechanistic details of cooperation between the Hippo and Rb pathways in the regulation of cell proliferation and identified new roles of these pathways. We discovered a novel function of the Rb pathway in the regulation of expression of mitochondria-associated genes and showed that the loss of such regulation results in severe mitochondrial defects, both in flies and in human tumor cells. We also showed that the Rb pathway has an essential function in Drosophila adult skeletal muscles that is necessary and sufficient for animal viability. Our proposal builds on these observations to investigate these new aspects of the Rb and Hippo pathways beyond their conventional role in cell proliferation. In particular, we will determine how the two pathways cooperate to regulate the mitochondrial function in flies and will use this knowledge to guide us towards improving the therapeutic effects of a CDK4/6 inhibitor in tumor cells. Additionally, we will explore the importance of the Rb pathway in adult skeletal muscles and define the underlying mechanisms. Finally, we will use a novel genetic cell-labeling system, single-cell approaches and advanced genomic tools to elucidate the molecular mechanisms by which the Hippo and Rb pathways maintain terminal differentiation in vivo. Collectively, these studies will enhance our knowledge of the cooperation of tumor suppressor pathways and will contribute to the identification of new therapeutic targets.
项目总结/摘要 在多细胞生物体中,细胞增殖和分化的控制由细胞的净输出决定。 多重途径这是由著名的Rb肿瘤抑制基因 途径和新兴的Hippo肿瘤抑制途径。然而,这些类型的研究 本质上是复杂的,因此模式生物如果蝇是有吸引力的替代品, 补充哺乳动物系统中的类似研究。这主要是由于相对简单, 果蝇Rb和Hippo通路的高度保守性。在上一个赠款周期,我们 探讨了海马和Rb通路在调节 细胞增殖,并确定了这些途径的新作用。我们发现了Rb的一个新功能 途径的调控,并表明,损失的表达, 这种调节导致果蝇和人类肿瘤细胞中严重的线粒体缺陷。我们也 表明Rb通路在果蝇成年骨骼肌中具有重要功能, 对于动物的生存能力来说是必要且足够的。我们的建议建立在这些观察的基础上, Rb和Hippo通路的这些新方面超出了它们在细胞增殖中的传统作用。在 特别是,我们将确定这两种途径如何合作,以调节果蝇线粒体功能 并将利用这些知识来指导我们提高CDK 4/6抑制剂的治疗效果, 肿瘤细胞此外,我们将探讨Rb通路在成人骨骼肌中的重要性, 定义潜在的机制。最后,我们将使用一种新的遗传细胞标记系统,单细胞 方法和先进的基因组工具来阐明海马和 Rb通路在体内维持终末分化。总的来说,这些研究将提高我们的 肿瘤抑制途径的合作知识,并将有助于确定新的 治疗目标

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maxim Frolov其他文献

Maxim Frolov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maxim Frolov', 18)}}的其他基金

Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
视网膜母细胞瘤肿瘤抑制途径控制细胞增殖和分化
  • 批准号:
    10396992
  • 财政年份:
    2019
  • 资助金额:
    $ 33.58万
  • 项目类别:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
视网膜母细胞瘤肿瘤抑制途径控制细胞增殖和分化
  • 批准号:
    10794727
  • 财政年份:
    2019
  • 资助金额:
    $ 33.58万
  • 项目类别:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
视网膜母细胞瘤肿瘤抑制途径控制细胞增殖和分化
  • 批准号:
    10611940
  • 财政年份:
    2019
  • 资助金额:
    $ 33.58万
  • 项目类别:
Control of cell proliferation and differentiation by the Retinoblastoma tumor suppressor pathway
视网膜母细胞瘤肿瘤抑制途径控制细胞增殖和分化
  • 批准号:
    9908112
  • 财政年份:
    2019
  • 资助金额:
    $ 33.58万
  • 项目类别:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
mir11~998内含子microRNA簇与视网膜母细胞瘤抑癌通路之间的功能相互作用
  • 批准号:
    8991496
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:
Functional interaction between the mir11~998 intronic microRNA cluster and Retinoblastoma tumor suppressor pathway
mir11~998内含子microRNA簇与视网膜母细胞瘤抑癌通路之间的功能相互作用
  • 批准号:
    8816779
  • 财政年份:
    2015
  • 资助金额:
    $ 33.58万
  • 项目类别:
Genetic integration of pRB and Hippo tumor suppressor pathways
pRB 和 Hippo 肿瘤抑制途径的基因整合
  • 批准号:
    8319369
  • 财政年份:
    2011
  • 资助金额:
    $ 33.58万
  • 项目类别:
Genetic integration of pRB and Hippo tumor suppressor pathways
pRB 和 Hippo 肿瘤抑制途径的基因整合
  • 批准号:
    8708116
  • 财政年份:
    2011
  • 资助金额:
    $ 33.58万
  • 项目类别:
Genetic integration of pRB and Hippo tumor suppressor pathways
pRB 和 Hippo 肿瘤抑制途径的基因整合
  • 批准号:
    8019364
  • 财政年份:
    2011
  • 资助金额:
    $ 33.58万
  • 项目类别:
Genetic integration of pRB and Hippo tumor suppressor pathways
pRB 和 Hippo 肿瘤抑制途径的基因整合
  • 批准号:
    8514010
  • 财政年份:
    2011
  • 资助金额:
    $ 33.58万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 33.58万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了